Adamas to Present at Upcoming BAML Investor Conference
Bank of America Merrill Lynch(BAML) 2019 Health Care Conferenceon Wednesday, May 15at 1:40 p.m. EDT( 10:40 a.m. PDT)
The presentation will be webcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. An archived version of the webcast will be available via replay for 30 days following the presentations.
Adamas’ goal is to create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology. For more information about Adamas and its unique approach to developing medicines based on time-dependent biology, please visit www.adamaspharma.com.
Managing Director, Westwicke
Vice President of Corporate Communications
Source: Adamas Pharmaceuticals, Inc.